Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Antipsychotic medications are primary treatments for schizophrenia and other psychoses.
• Understanding their molecular brain effects is limited by tissue access and disease confounders.

Purpose of the Study:

• To investigate gene expression and DNA methylation differences linked to antipsychotic drug toxicology in the human caudate nucleus.
• To compare these molecular changes with schizophrenia and mouse models.

Main Methods:

• Analysis of gene expression and DNA methylation in human caudate nucleus tissue.
• Comparison of findings with existing data from schizophrenia cases and a mouse model.

Main Results:

• No genome-wide significant DNA methylation differences were found.
• Abundant gene expression differences were observed, largely mirroring those in schizophrenia.
• Gene expression changes varied across brain regions and differed from mouse model effects.

Conclusions:

• Antipsychotic toxicology significantly impacts gene expression in the human brain, but not DNA methylation.
• Observed gene expression patterns resemble schizophrenia, suggesting shared molecular pathways.
• Brain region-specific effects and discrepancies with mouse models highlight the complexity of antipsychotic action.